Louis Lehot on Biotech IPOs – 'Biotech could have a great fourth quarter'
04 September 2024
Bloomberg Law
Foley & Lardner LLP partner Louis Lehot offered insight on the biotech industry’s upcoming initial public offerings in the Bloomberg Law article, “Biotech IPO Hopefuls Ready Burst of Debuts After Rough Stretch.”
“Biotech could have a great fourth quarter, we have a great pipeline,” Lehot commented, as several biotech companies look to reignite the sector with upcoming IPOs. “Biotech IPOs are here and ready to put money to work.”
(Subscription required)
People
Related News
04 April 2025
In the News
Ann Marie Uetz Quoted on New Tariffs Effect on Automotive Industry
Foley & Lardner LLP partner Ann Marie Uetz shared insights on how new tariffs are impacting supply chains and the automotive industry in a Bloomberg live blog covering all aspects of the Trump administration’s tariff announcement and rollout.
04 April 2025
In the News
Vanessa Miller on Impact of ‘Liberation Day’ Tariffs on Automotive Industry – ‘Disputes Could Escalate Quickly'
Foley & Lardner LLP partner Vanessa Miller discussed how the automotive industry is reacting to the Trump administration’s “Liberation Day” announcement of new tariffs in The Detroit News article, “Trump tariffs prompt retaliation, plunging stocks, auto plant shutdowns.”
04 April 2025
In the News
Vanessa Miller Comments on Impact of Tariffs on EVs
Foley & Lardner LLP partner Vanessa Miller describes how new tariffs are impacting the electric vehicle (EV) industry in the Associated Press article, “US electric vehicle industry is collateral damage in Trump’s escalating trade war.